Request for ADAMHA Research Scientist Award. (1) Oral, schedule-induced (S-I) drug overindulgence, and chronic drug preference compared to vehicle, will be studied, especially as determined by the history of the environmental stimulus control (S/D) of preference, and current pharmacological factors. Drugs considered will be extended from cocaine to caffeine, midazolam and nicotine. Emphasis will be on tracing the situational sources initiating and maintaining drug abuse under conditions wherein pharmacologic impact is minimized, but functionally significant (oral route), while the environmental determination (S-I and S/D control) of the behavior maximized. This endeavors to clarify drug abuse initiation by an analysis of the gateways, both situational and pharmacologic, that make its acquisition probable. (2) Excessive drug intake can compromise ensuing behavioral functions. Both unconditioned behavior (e.g., locomotor activity) and psychomotor performance (e.g., fine-motor control and timing behaviors) will be measured after acute and chronic oral drug self-administration, and the resulting profiles related to a drug's measured serum concentration-time profile. (3) Results from oral self-administration will be compared to those of parenteral drug imposition.
The aim i s to predict whether serum pharmacokinetic concentration-time profiles of parent compounds and their active metabolites predict the concurrent behavior-time profiles. (4) Studies pay special attention to the behavior and kinetics of drug interactions, as concurrent use and abuse of substances, both licit and illicit, commonly occurs.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
2K05DA000142-06
Application #
2115981
Study Section
Special Emphasis Panel (SRCD)
Project Start
1995-02-01
Project End
2000-01-31
Budget Start
1995-02-01
Budget End
1996-01-01
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Rutgers University
Department
Psychology
Type
Schools of Arts and Sciences
DUNS #
038633251
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Wang, Q; Simpao, A; Sun, L et al. (2001) Contribution of the active metabolite, norcocaine, to cocaine's effects after intravenous and oral administration in rats: pharmacodynamics. Psychopharmacology (Berl) 153:341-52
Lau, C E; Sun, L; Wang, Q et al. (2000) Oral cocaine pharmacokinetics and pharmacodynamics in a cumulative-dose regimen: pharmacokinetic-pharmacodynamic modeling of concurrent operant and spontaneous behavior within an operant context. J Pharmacol Exp Ther 295:634-43
Lobarinas, E; Falk, J L (2000) Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats. Psychopharmacology (Berl) 149:176-80
Lau, C E; Ma, F; Foster, D M et al. (1999) Pharmacokinetic-pharmacodynamic modeling of the psychomotor stimulant effect of cocaine after intravenous administration: timing performance deficits. J Pharmacol Exp Ther 288:535-43
Lobarinas, E; Falk, J L (1999) Dose-dependent effects but not sensitization of DRL 45-s performance by oral d-amphetamine with cumulative- and repeated-dosing regimens. Behav Pharmacol 10:739-46
Ma, F; Falk, J L; Lau, C E (1999) Cocaine pharmacodynamics after intravenous and oral administration in rats: relation to pharmacokinetics. Psychopharmacology (Berl) 144:323-32
Lobarinas, E; Lau, C E; Falk, J L (1999) Sensitization of operant behavior to oral cocaine with increasing- and repetitive-dose regimens. Behav Pharmacol 10:15-26
Lau, C E; Wang, Y; Sun, L et al. (1999) Pharmacokinetic determinants of cocaine's differential effects on locomotor and operant behavior. Eur J Pharmacol 381:85-92
Falk, J L; Yosef, E; Schwartz, A et al. (1999) Establishing oral preference for quinine, phencyclidine and caffeine solutions in rats. Behav Pharmacol 10:27-38
Ma, F; Falk, J L; Lau, C E (1999) Within-subject variability in cocaine pharmacokinetics and pharmacodynamics after intraperitoneal compared with intravenous cocaine administration. Exp Clin Psychopharmacol 7:3-12

Showing the most recent 10 out of 25 publications